Revolutionizing validation

The client, Biogen Inc., contracted Kneat to deliver their vision for the future of laboratory operations. Biogen Inc. (previously known as Biogen Idec) is an American multinational biotechnology company specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases.

The client, a US headquartered tier one biotech with multiple facilities in the US and the EU, achieved productivity improvements of 100% after digitizing validation on the Kneat platform.

The client, a leading molecular diagnostic company, is dedicated to saving and improving lives by discovering and delivering tests across major diseases. They produce their own proprietary software which requires validation and FDA compliance and have been successfully using Kneat for Computer System Validation since 2014.

A frustration with the complexity, inefficiency, and error strewn nature of paper-based validation led the client to explore possible solutions. What began as a commissioning and qualification validation project, has led to rolling out Kneat’s solution to many more validation processes.